Cargando…

Drug–Drug Interactions Of Amiodarone And Quinidine On The Pharmacokinetics Of Eliglustat In Rats

BACKGROUND: Eliglustat, a new oral substrate-reduction therapy, was recently approved as a first-line therapy for Gaucher's disease type 1 (GD1) patients. PURPOSE: The purpose of the present study was to develop and validate a simple UPLC-MS/MS method for the measurement of plasma-eliglustat co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiong, Wang, Haiyun, Zhong, Youyan, Zhang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913762/
https://www.ncbi.nlm.nih.gov/pubmed/31849452
http://dx.doi.org/10.2147/DDDT.S226948